Vaccinium Myrtillus Market to Garner Brimming Revenues by 2018 2028
Posted by Arslan on September 10th, 2019
Vaccinium myrtillus is a relative of the blueberry, widely found in diverse areas, including the Rocky Mountains and regions of Asia and Europe. The growing use of Vaccinium myrtillus as a dietary supplement for eye problems, cardiovascular conditions, diabetes, urinary tract infections, and diarrhea is creating lucrative growth opportunities for the stakeholders.
Extensive adoption of bilberry extract in drops, tablets, and capsules, in dried and powdered forms, are underpinning gains in the Vaccinium myrtillus Market. Growing traction for natural and organic ingredients in food and dietary supplements, backed by shifting consumer preference for clean label products is providing impetus to the growth in the Vaccinium myrtillus market.
High health benefits of bilberry continue to drive growth in the Vaccinium myrtillus market, however, according to the National Institutes of Health (NIH) researchers lack scientific evidence to back the use of this shrub for any kind of health condition.
The growing use of vaccinium myritillus coupled with the concerns pertaining to its effectiveness for medicinal uses has led companies to invest in its R&D. Researchers are keen to study vaccinium myrtillus on a large scale because their berries have a high concentration of antioxidants known as anthocyanins, which some studies suggest potentially have health benefits.
Companies are increasingly exploring the potentially viable applications of Vaccinium myrtillus to gain an extra edge in the market. Increasing penetration of advanced technology in the R&D sector is likely to bring positive changes in the Vaccinium myrtillus market.
Global Vaccinium myrtillus Market Overview
Vaccinium myrtillus, commonly known as wimberry, bilberry, European blueberry or whortleberry, is a species of shrubs with blue color edible fruit of high medicinal values. Vaccinium myrtillus is distinctly known as common bilberry or blue whortleberry in order to distinguish from other Vaccinium species. Vaccinium myrtillus is majorly found in Europe, Greenland, Iceland, northern Asia, U.S. and Canada. However, majority of the Vaccinium myrtillus is produced in Eastern Europe regions. Vaccinium myrtillus are majorly found in the wild on acidic soil conditions. Vaccinium myrtillus find its application in varieties of end-use industry verticals, and hence a positive outlook can be witnessed for Vaccinium myrtillus market in the upcoming years.
Global scenario of increasing disease burden and extensive R&D efforts for the innovation of drugs are the prime factors supporting the explosively growing pharmaceutical industry world. According to the American Diabetes Association, over 30.3 million Americans were diagnosed with diabetes, which was proved to be the leading cause of death in the United States, in 2015. With increasing prevalence of diabetes, demand for Vaccinium myrtillus products is expected to witness a rise in the U.S and other regions around the world. According to a study published in European Review for Medical and Pharmacological Sciences, Vaccinium myrtillus can be used to provide relief for dry eyes. Vaccinium myrtillus can be used to reduce eye discomfort, where Vaccinium myrtillus extracts plays a vital role in improving tear secretion and plasmatic antioxidant potential in patients suffering from dry eye. According to University of Maryland Medical Center, Vaccinium myrtillus are very rich in anthocyanosides which helps in assisting the viability of blood vessels and ensures healthy circulation throughout the body including capillaries in the eyes. More comprehensive research on Vaccinium myrtillus reveals anthocyanosides present in Vaccinium myrtillus accelerates formulation of the pigment called rhodopsin, which helps in the eyes’ ability to see in darkness as well as improves the adaptability of eyes towards changing light intensity. Vaccinium myrtillus also helps delay cataract development. Vaccinium myrtillus contains a significant amount of anthocyanosides, which assists in minimizing blood clot because of its properties to thwart blood platelets from aggregating. Moreover, anthocyanosides are antioxidants and helps in preventing the oxidizing of cholesterol. Improved vision, reduction in hemorrhagic tendencies in the eyes, improved blood vessel structure are some of the factors because of which Vaccinium myrtillus is widely used in the pharmaceutical industry. High medicinal properties of Vaccinium myrtillus and increasing health-related issues will drive the Vaccinium myrtillus in the forecast period. High demand for Vaccinium myrtillus can be seen in the upcoming years but there are few factors which might impede the overall growth of Vaccinium myrtillus market. Some factors includes adulteration Vaccinium myrtillus extract. Vaccinium myrtillus are often adulterated with intensive dark blue color, such as anthocyanidin-containing extracts or red food coloring such as amaranth dye. Such extracts and dye are harmful for human consumptions. Also, rising global geopolitical tensions resulting in trade wars will negatively impact the overall growth of the Vaccinium myrtillus market during the forecast period.
Global Vaccinium myrtillus Market Segmentation
Vaccinium myrtillus can be segmented on the basis of product type, end-use application and nature. On the basis of product type, Vaccinium myrtillus can be further segmented as fruit extract and leaf extract. On the basis of end-use application, Vaccinium myrtillus can be further segmented as food and bakery products, pharmaceutical industry and cosmetic and personal care industry. Vaccinium myrtillus is widely used in jams, fools, juices and pies. On the basis of nature, the market can be further segmented as fresh and frozen. Frozen form to account for comparatively more share than fresh Vaccinium myrtillus.
Global Vaccinium myrtillus Market Regional Outlook and Competition Tracking
High demand for Vaccinium myrtillus can be seen in North America and Europe region. In the U.S., Vaccinium myrtillus was among the top 20 herbal supplements between 2007 and 2012 in the food and pharmaceutical market. Asia Pacific and Latin America to register high CAGR during the forecast period. Some of the leading manufacturers of Vaccinium myrtillus includes Eevia Health Oy, ETchem, Sanyuan Jinrui Natural Ingredients Co., Ltd, BioMax Life Sciences, NOW Foods, Bio-Botanica, and other global and local players.
Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2081
Like it? Share it!
About the AuthorArslan
Joined: December 18th, 2017
Articles Posted: 13,297
More by this author